FAM111B and prostate carcinoma: Last, FAM111B has been implicated insusceptibility to prostate cancer by a genome-wide association study (Akamatsu et al., 2012) and it hasbeen indicated as an unfavourable prognostic marker in pancreatic and liver cancer(https://www.proteinatlas.org/ENSG00000189057-FAM111B).